Diabetic ketoacidosis and the hyperosmolar hyperglycaemic state are both hyperglycaemic emergencies, but they differ in their physiology, the people they affect and how they present. The differences are tested often in exams and matter at the bedside.
Diabetic ketoacidosis
DKA results from a severe lack of insulin, which allows uncontrolled breakdown of fat into ketones and leads to metabolic acidosis. UK guidance defines it by three features: raised blood ketones or significant ketonuria, raised blood glucose or known diabetes, and acidosis shown by a low bicarbonate or low venous pH.
DKA typically affects people with type 1 diabetes, often triggered by infection, missed insulin or new diagnosis. It develops over hours. Euglycaemic DKA, in which the glucose is near normal, is recognised particularly in people taking SGLT2 inhibitors, so a normal glucose does not exclude it.
Hyperosmolar hyperglycaemic state
HHS results from a relative lack of insulin. There is enough insulin to prevent significant ketone production, but not enough to control glucose. The result is very high glucose, marked dehydration and high serum osmolality without significant acidosis.
HHS typically affects older people with type 2 diabetes, sometimes as the first presentation, and develops over days. Patients are often profoundly dehydrated and may be confused or drowsy. The risk of thrombosis is high.
Why the distinction matters
The two conditions are managed differently, so recognising which one is present, or whether there are features of both, is the first step. Mixed presentations do occur.
For exams
- Learn the defining features of each.
- Look for the patient group and the speed of onset.
- Remember euglycaemic DKA with SGLT2 inhibitors.
- Calculate serum osmolality when the numbers are given.
The Endocrinology revision book covers diabetes and endocrine emergencies, for physicians preparing for exams and those updating their knowledge.